相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Inflammatory cytokines, high-sensitivity C-reactive protein, and risk of one-year vascular events, death, and poor functional outcome after stroke and transient ischemic attack
S. Coveney et al.
INTERNATIONAL JOURNAL OF STROKE (2022)
Interleukin-6 and YKL-40 predicted recurrent stroke after ischemic stroke or TIA: analysis of 6 inflammation biomarkers in a prospective cohort study
Jiejie Li et al.
JOURNAL OF NEUROINFLAMMATION (2022)
Effect of different doses of colchicine on high sensitivity C-reactive protein in patients with acute minor stroke or transient ischemic attack: A pilot randomized controlled trial
Baoshi Yuan et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2022)
Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE) - study protocol for a randomised controlled trial
Peter Kelly et al.
EUROPEAN STROKE JOURNAL (2021)
Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA
Yongjun Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Residual Risk and Its Risk Factors for Ischemic Stroke with Adherence to Guideline-Based Secondary Stroke Prevention
Yuesong Pan et al.
JOURNAL OF STROKE (2021)
Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials
Aernoud T. L. Fiolet et al.
EUROPEAN HEART JOURNAL (2021)
Residual Inflammatory Risk Predicts Poor Prognosis in Acute Ischemic Stroke or Transient Ischemic Attack Patients
Jiejie Li et al.
STROKE (2021)
Inflammation and Stroke Risk: A New Target for Prevention
Peter J. Kelly et al.
STROKE (2021)
Interleukin-6, C-reactive protein, fibrinogen, and risk of recurrence after ischaemic stroke: Systematic review and meta-analysis
J. J. McCabe et al.
EUROPEAN STROKE JOURNAL (2021)
Colchicine in Patients with Chronic Coronary Disease
Stefan M. Nidorf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Anticytokine Agents Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis
Paul M. Ridker
CIRCULATION RESEARCH (2019)
The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient characteristics
Yongjun Wang et al.
STROKE AND VASCULAR NEUROLOGY (2019)
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Anti-inflammatory approaches to ischaemic stroke prevention
Peter J. Kelly et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
The NLRP3 inflammasome in acute myocardial infarction
Stefano Toldo et al.
NATURE REVIEWS CARDIOLOGY (2018)
Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)
Paul M. Ridker et al.
EUROPEAN HEART JOURNAL (2018)
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
Paul M. Ridker et al.
LANCET (2018)
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA
S. Claiborne Johnston et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Inflammatory Markers and Outcomes After Lacunar Stroke Levels of Inflammatory Markers in Treatment of Stroke Study
Amelia K. Boehme et al.
STROKE (2016)
High-Sensitive C-Reactive Protein Predicts Recurrent Stroke and Poor Functional Outcome Subanalysis of the Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events Trial
Jiejie Li et al.
STROKE (2016)
Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
Yongjun Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
Nadeem Sarwar et al.
LANCET (2012)
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
Daniel I. Swerdlow et al.
LANCET (2012)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Rhabdomyolysis in a patient treated with colchicine and atorvastatin
Abdurrahman Tufan et al.
ANNALS OF PHARMACOTHERAPY (2006)
Colchicine myotoxicity: Case reports and literature review
K Wilbur et al.
PHARMACOTHERAPY (2004)
Cytoskeletal myotoxicity from simvastatin and colchicine
SK Baker et al.
MUSCLE & NERVE (2004)